期刊文献+

左氧氟沙星多组分晶体的制备与性能研究

Preparation and property study of levofloxacin multi-component crystals
在线阅读 下载PDF
导出
摘要 以左氧氟沙星为模型药物,采用偏最小二乘回归模型预测了可能与左氧氟沙星形成多组分晶体的配体,以指导左氧氟沙星多组分晶体样品的制备,并探究了样品的稳定性和体外抗菌活性。结果表明,所选17种配体中,7种配体成功与左氧氟沙星形成多组分晶体,其中5种配体被预测模型命中。各预测模型中,汉森溶解度参数/COSMO-RS双参数预测模型的准确率最高,对实验体系的总体准确率和阳性准确率分别为82.4%和83.3%。其中5种多组分晶体样品的稳定性与稳定性良好的原料药相当,且所制备的7种多组分晶体样品的抗菌活性均明显提高,预期在实现与原料药同等抗菌活性的前提下,可有效降低给药剂量,减少不良反应。 Multi-component crystal is an effective way to improve the physicochemical and biochemical properties of drugs.Levofloxacin(LEV)is an antibacterial and anti-infective drug with high solubility and high antibacterial activity,but still exists some adverse effects.In this study,LEV was selected as the model drug,and partial least squares regression(PLS)models were used to predict the co-formers that might form multi-component crystals with levofloxacin.Guided by the prediction results,LEV multicomponent crystals were prepared,then the stability and in vitro antibacterial activity of the samples were investigated.The results show that 7 of the 17 selected co-formers are successfully prepared as multi-component crystals with LEV,and 5 co-formers are successfully hit by the prediction results.Among the prediction models,the Hansen solubility parameter/COSMO-RS two-parameter prediction model has the highest accuracy,with an overall accuracy of 82.4%and a positive accuracy of 83.3%for the experimental systems,respectively.The stability of 5 multi-component crystal samples prepared is not significantly altered compared to the stable raw LEV,and the antibacterial activity against E.coli and S.aureus of all 7 prepared multi-component crystal samples is obviously improved.While achieving the same antibacterial activity as the raw LEV,it is expected that the prepared multi-component crystals would be effective in reducing the dose of the drug and reducing adverse effects.
作者 陈武 顾振东 郑智勇 梁小小 刘诗苑 江燕斌 CHEN Wu;GU Zhendong;ZHENG Zhiyong;LIANG Xiaoxiao;LIU Shiyuan;JIANG Yanbin(Star Lake Bioscience Co.Inc.,Guangdong,Zhaoqing 526040,China;School of Chemistry and Chemical Engineering,South China University of Technology,Guangzhou 510640,China)
出处 《化学工业与工程》 CSCD 北大核心 2024年第6期136-148,共13页 Chemical Industry and Engineering
基金 国家自然科学基金(22178121)
关键词 左氧氟沙星 多组分晶体 配体筛选 制备 性能 levofloxacin multi-component crystal co-former screening preparation property
  • 相关文献

参考文献7

二级参考文献58

  • 1卞正岗.高端智能装备与自动化技术[J].自动化博览,2011,28(S1):2-5. 被引量:2
  • 2姜铭,李成建.经母乳摄入左氧氟沙星致锥体外系反应1例[J].中国误诊学杂志,2007,7(12):2929-2929. 被引量:9
  • 3中华人民共和国卫生部,国家中医药管理局,中国人民解放军总后勤部卫生部.抗菌药物临床应用指导原则[EB/OL].http://www.sda.gov.cn/WS01/CL0056/10752.html,2004-08-19.
  • 4国家药品不良反应监测中心.药品不良反应信息通报(第22期)[J/OL].http://www.cdr.gov.cn.2009-05-21.
  • 5Karim A,Ahmed S,Rossoff LJ,et al.Possible levofloxacin-in-duced acute hepatocellular injury in a patient with chronic obstructivelung disease[J].Clin Infect Dis,2001;33:2088-2090.
  • 6Carrascosa MF,Lucena MI,Andrade RJ,et al.Fatal acute hepatitisafter sequential treatment with levofloxacin,doxycycline,and naprox-en in a patient presenting with acute Mycoplasma pneumoniae infec-tion[J].Clin Ther,2009;31:1014-1019.
  • 7Leung DH, Lohani S, Ball RG,ef al. Two novel pharmaceuticalcocrystals of a development compound-screening, scale-up, andcharacterization [ J ]. Cryst Growth Des,2012,12 ( 3 ) : 1 254 -1262.
  • 8Trask AV. An overview of pharmaceutical cocrystals as intellectu-al property[J].Mol Pharm,2001,4(3) :301 -309.
  • 9Sunil SL,Nayak SK,Hathwar VR,eJ al. Role of fluorine in weakinteractions in co-crystals [ M ]//Thurston D. Pharmaceuticalsalts and co-crystals. Cambridge : Royal Society of Chemistry,2011:29 -43.
  • 10Fleischman SG,Kuduva SS,McMahon JA,et al. Crystal engineer-ing of the composition of pharmaceutical phases : multiple-compo-nent crystalline solids involving carbamazepine[ J]. Cryst GrowthDes,2003,3(6) :909 -919.

共引文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部